Literature DB >> 11861367

Enhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells.

Michael A Burg1, Kristen Jensen-Pergakes, Ana Maria Gonzalez, Prenn Ravey, Andrew Baird, David Larocca.   

Abstract

Engineered phage-based vectors are an attractive alternative strategy for gene delivery because they possess no natural mammalian cell tropism and can be genetically modified for specific applications. Genotoxic treatments that increase the transduction efficiency of single-stranded adeno-associated virus were tested on cells transfected by single-stranded phage. Indeed, green fluorescent protein transgene expression by epidermal growth factor-targeted phagemid particles increased with heat shock, UV irradiation, and camptothecin (CPT) treatment. CPT resulted in transduction efficiencies of 30-45% in certain human carcinoma cell lines and reduced the minimal dose needed to detect green fluorescent protein-expressing cells to as low as 1-10 particles/cell. Targeted phage transduction was effective in many tumor cell lines and in prostate tumor xenografts with CPT treatment. Taken together, these data suggest the feasibility of using phage-based vectors for therapeutic gene delivery to cancer cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861367

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.

Authors:  Ana Maria Gonzalez; Wendy Leadbeater; Sonia Podvin; Alexandra Borboa; Michael Burg; Ritsuko Sawada; James Rayner; Karen Sims; Tetsuya Terasaki; Conrad Johanson; Edward Stopa; Brian Eliceiri; Andrew Baird
Journal:  Brain Res       Date:  2010-08-21       Impact factor: 3.252

Review 2.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 3.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

4.  Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4.

Authors:  Xitong Dang; Raul Coimbra; Liang Mao; Sonia Podvin; Xue Li; Hua Yu; Todd W Costantini; Xiaorong Zeng; Dana Larocca; Brian P Eliceiri; Andrew Baird
Journal:  Cell Mol Life Sci       Date:  2019-06-12       Impact factor: 9.261

5.  Pseudovirions as vehicles for the delivery of siRNA.

Authors:  Paul E Lund; Ryan C Hunt; Michael M Gottesman; Chava Kimchi-Sarfaty
Journal:  Pharm Res       Date:  2009-12-09       Impact factor: 4.200

6.  Gene transfer into Mammalian cells using targeted filamentous bacteriophage.

Authors:  Andrew Baird
Journal:  Cold Spring Harb Protoc       Date:  2011-08-01

7.  Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.

Authors:  Andrew Baird; Brian P Eliceiri; Ana Maria Gonzalez; Conrad E Johanson; Wendy Leadbeater; Edward G Stopa
Journal:  Methods Mol Biol       Date:  2011

8.  Targeting the gut barrier: identification of a homing peptide sequence for delivery into the injured intestinal epithelial cell.

Authors:  Todd W Costantini; James G Putnam; Ritsuko Sawada; Andrew Baird; William H Loomis; Brian P Eliceiri; Vishal Bansal; Raul Coimbra
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

Review 9.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

10.  Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain.

Authors:  Stefania Piersanti; Gioia Cherubini; Yuri Martina; Barbara Salone; Daniele Avitabile; Fabiana Grosso; Enrico Cundari; Giovanni Di Zenzo; Isabella Saggio
Journal:  J Mol Med (Berl)       Date:  2004-05-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.